Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes

Aims/hypothesis We determined whether empagliflozin altered renal sympathetic nerve activity (RSNA) and baroreflexes in a diabetes model in conscious rabbits. Methods Diabetes was induced by alloxan, and RSNA, mean arterial pressure (MAP) and heart rate were measured before and after 1 week of treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetologia 2020-07, Vol.63 (7), p.1424-1434
Hauptverfasser: Gueguen, Cindy, Burke, Sandra L., Barzel, Benjamin, Eikelis, Nina, Watson, Anna M. D., Jha, Jay C., Jackson, Kristy L., Sata, Yusuke, Lim, Kyungjoon, Lambert, Gavin W., Jandeleit-Dahm, Karin A. M., Cooper, Mark E., Thomas, Merlin C., Head, Geoffrey A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aims/hypothesis We determined whether empagliflozin altered renal sympathetic nerve activity (RSNA) and baroreflexes in a diabetes model in conscious rabbits. Methods Diabetes was induced by alloxan, and RSNA, mean arterial pressure (MAP) and heart rate were measured before and after 1 week of treatment with empagliflozin, insulin, the diuretic acetazolamide or the ACE inhibitor perindopril, or no treatment, in conscious rabbits. Results Four weeks after alloxan administration, blood glucose was threefold and MAP 9% higher than non-diabetic controls ( p  
ISSN:0012-186X
1432-0428
DOI:10.1007/s00125-020-05145-0